Rabies Diagnostics Market to Grow at 4.6% CAGR by 2031

United States of America — [18 September, 2025] — The Insight Partners is proud to announce its newest market report, "Rabies Diagnostics Market: An In-depth Analysis of the Global Rabies Diagnostics Market." The report delivers a holistic view of the Rabies Diagnostics Market, describing the current landscape and growth estimates during the forecast period.

Overview of Rabies Diagnostics Market

The Rabies Diagnostics Market is projected to grow at a CAGR of 4.6% from 2025 to 2031, with the market size expected to expand from US$ XX million in 2024 to US$ XX million by 2031. Shifting market dynamics, including technological advancements in diagnostics, government awareness campaigns, and increased demand for rapid testing, are key forces influencing growth.

Key Findings and Insights

Market Size and Growth

• Historical & Forecast Data: The Rabies Diagnostics Market is estimated to achieve significant growth by 2031 with a CAGR of 4.6%.
• Key Factors Affecting the Market:
  • Rising incidence of rabies cases globally.
  • Government initiatives and awareness campaigns.
  • Technological advancements such as PCR, ELISA, and rapid diagnostic kits.
  • Increasing veterinary diagnostics to prevent human transmission.

Market Segmentation

• By Diagnosis: Fluorescent Antibody Test (FAT), Immunohistochemical Test, Amplification Methods, Histologic Examination, Serology Tests.
• By Technology: Immunohistochemistry, Chromatography Techniques, PCR, Others.
• By Geography: North America (US, Canada, Mexico), Europe (UK, Germany, France, Italy, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, Rest of APAC), South and Central America (Brazil, Argentina, Rest of South and Central America), Middle East & Africa (South Africa, Saudi Arabia, UAE, Rest of MEA).

Spotting Emerging Trends

• Technological Advancements: Growth of molecular diagnostics, PCR/RT-PCR, and point-of-care testing.
• Changing Preferences: Increased use of diagnostic kits in veterinary care and field testing.
• Regulatory Changes: Government funding for rabies elimination programs and improved global disease monitoring standards.

Growth Opportunities

• Expansion of veterinary diagnostics for early detection in animals.
• Development of rapid and field-friendly diagnostic kits for underserved regions.
• Government support and funding for rabies control programs, including diagnostic initiatives.
• Partnerships with veterinary hospitals and clinics to expand diagnostic accessibility.

Conclusion

The Rabies Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023–2031 report provides vital insights for stakeholders evaluating opportunities in this sector. With in-depth analysis of competitive dynamics, regulatory landscape, and technological advancements, the report is an essential resource for companies and investors planning to expand within the rabies diagnostics space.

Key Companies Profiled:
MyBioSource.com, BioNote Inc., Express Biotech International Inc., Abbexa Ltd, Demeditec Diagnostics GmbH, Merck KGaA, Creative Diagnostics, Bio-Rad Laboratories Inc., Aviva Systems Biology Corporation.

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.

Contact Us:
If you have any queries about this report or if you would like further information, please get in touch with us:
Contact Person: Ankit Mathur
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876
Also Available in : 日本 | 한국어 | Français | لعربية< | 中文 | Italiano | Español | Deutsch